Uveal melanoma trapped in the temple of doom

American Journal of Ophthalmology

Volumn 154, Issue 2, 2012, Pages 219-221

  Shields, Carol L ^a   Ganguly, Arupa ^b   O'Brien, Joan ^b   Sato, Takami ^c   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CHOROID MELANOMA; CHROMOSOME 3; DNA CONTENT; EDITORIAL; GENE EXPRESSION PROFILING; HUMAN; METASTASIS; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRIORITY JOURNAL; PROGNOSIS; SOMATIC MUTATION; TUMOR VOLUME; UVEA MELANOMA;

EID: 84866403443     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2012.03.009     Document Type: Editorial

References (17)

1. Shields CL, Furuta M, Thangappan A, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol 2009;127(8):989 -998.
2. Scholes AGM, Damato BE, Nunn J, et al. Monosomy 3 in uveal melanoma: Correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 2003;44(3):1008-1011.
3. Shields CL, Ganguly A, Bianciotto CG, Turaka K, Shields JA. Prognosis of uveal melanoma in 500 cases using genetic testing of needle aspiration biopsy specimens. Ophthalmology 2011;118(2):396-401.
4. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: A 7-year clinical experience. Ophthalmology 2007;114(10):1925-1931.
5. Tschentscher F, Hüsing J, Hölter T, et al. Tumor classification based on gene expression profiling shows that uveal melanoma with and without monosomy 3 represents tow distinct entities. Cancer Res 2003;63(10):2578 -2584.
6. Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004;64(20):7205-7209.
7. Van Raamsdonk CD, Griewank KG, Crosby MB, et al. Mutatations in GNA11 in uveal melanoma. N Engl J Med 2010;363(23):2191-2199.
8. Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010;330(6009):1410 -1413.
9. Patel M, Smyth E, Chapman PB, et al Therapeutic implications of the emerging molecular biology of uveal melanoma. Clin Cancer Res 2011;17(8):2087-2100.
10. Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996; 347(9010):1222-1225.
11. Damato B, Dopierala JA, Coupland SE. Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe. Clin Cancer Res 2010;16(24): 6083-6092.
12. Spagnolo F, Caltabiano G, Queirolo P. Uveal melanoma. Cancer Treat Rev 2012;38(5):549-553.
13. Chappell MC, Char DH, Cole TB, et al. Uveal melanoma: molecular pattern, clinical features, and radiation response. Am J Ophthalmol 2012;154(2):227-232.
14. Shields CL, Bianciotto C, Rudich D, et al. Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status. Retina 2008;28(9):1289-1295.
15. Glynn RJ, Seddon JM, Gragoudas ES, et al. Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton irradiation of uveal melanoma. Ophthalmology 1989;96(10):1566 -1573.
16. Kaiserman I, Anteby I, Chowers I, et al. Post-brachytherapy initial tumor regression rate correlates with metastatic spread in posterior uveal melanoma. Br J Ophthalmol 2004;88(7): 892-895.
17. Marathe OS, Wu J, Lee SP, et al. Ocular response of choroidal melanoma with monosomy 3 versus disomy 3 after iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys 2011; 81(4):1046 -1048.